Latest News
US may impose sanctions against Nord Stream 2
Washington may announce further sanctions against the Russian Federation as soon as Wednesday, including against a key gas pipeline.
Thursday preview: EU leaders' summit, BAE Systems in focus
In all likelihood, all eyes on Thursday will be on the ongoing crisis in Ukraine, with investors trying to anticipate what the next turn in events might hold.
Europe close: Stocks yield early gains on talk of further sanctions
Stock markets across Europe yielded their earlier gains in late afternoon trading, amid talk regarding the potential for further sanctions from the West on Russia.
London close: Stocks mixed again as investors await Russia's next move
London stocks were mixed again at the close on Wednesday, with the top-flight index helped along by well-received results from Barclays, while investors kept an eye on developments in the Russia-Ukraine crisis.
Poll results for Ukrainians' support for Nato membership and non-aligned status are mixed
Do Ukrainians support joining Nato or would they rather that their country choose non-aligned status?.
Director dealings: Polar Capital director invests £0.3m, Kestrel buys more of ULS
Polar Capital Holdings disclosed a purchase made by one of its directors on Wednesday, worth almost £0. 3m.
FTSE 250 movers: Hochschild loses its shine; Darktrace boosted by acquisition
London’s FTSE 250 was down 0. 4% at 20,900. 95 in afternoon trade on Wednesday.
Broker tips: Next Fifteen Communications, Begbies Traynor, Dechra Pharmaceuticals
Analysts at Berenberg hiked their target price on media outfit Next Fifteen Communications from 1,500. 0p to 1,600. 0p on Wednesday following a "huge contract win" for the firm.
Faron upbeat on updated data from cancer treatment study
Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced updated survival data from the phase 1 and 2 study investigating the safety and efficacy of ‘bexmarilimab’ on Wednesday.
BiVictriX adds two new drug development programmes
Biotechnology company BiVictriX Therapeutics announced the expansion of its therapeutic pipeline on Wednesday, with two additional programmes - ‘BVX002’ and ‘BVX003’ - both entering the early stages of drug development.
BoE governor urges restraint in face of surging inflation
Bank of England governor Andrew Bailey insisted on Wednesday that both workers and companies must show restraint in the face of surging inflation.
Genedrive makes progress with rapid Covid-19 test kit
Molecular diagnostics company Genedrive updated the market on progress on the ‘Genedrive COV19-ID’ kit - its rapid point of care molecular test for Covid-19 - on Wednesday.
FTSE 100 movers: Barclays rallies on results; Kingfisher hit by downgrade
London’s FTSE 100 was up 0. 1% at 7,499. 09 in afternoon trade on Wednesday.
Begbies Traynor trading in line, administrations still lower
Business recovery, financial advisory and property services company Begbies Traynor Group said in an update on Wednesday that trading performance in the third quarter was “broadly in line” with the first half.
US open: Stocks flat as Russia-Ukraine tensions remain in focus
Wall Street stocks were little changed early on Wednesday after the S&P 500 closed out the previous session in correction territory.
Shares in Danone spark on strong end to year
Danone reported full-year sales narrowly ahead of forecasts on Wednesday, sending shares in the French food group higher.
Government to discuss Russia sanctions with City firms
The government is to discuss the imposition of potentially tougher financial sanctions on Russia with key City institutions, it was reported on Wednesday.
Seeing Machines revenue rises as it renews technology focus
Driver monitoring technology company Seeing Machines said in a trading update on Wednesday that it was expecting to report first-half revenue of AUD 21. 7m (£11. 61m), representing a year-on-year improvement of 19. 4%, and an underlying growth rate of 24. 6%.
Clinigen revenue rises as shareholders approve its acquisition
Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238. 1m.
RWS Holdings reports solid start to new financial year
Language, content and intellectual property service provider RWS Holdings said in an update on Wednesday that it had started its financial year “well”, and was trading in line with market expectations.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.
The value of investments can fall and you may get back less than you invested.